Granted Patent
Utility
US 5,874,082 · App. 08/606,293
Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation
Inventor:
Mark de Boer
Patented Case
View Patent ↗
Granted: Feb 23, 1999
Filed: Feb 23, 1996
Inventor
Mark de Boer
Assignee (at issue)
Chiron Corporation
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.